Patent Term Extension Application for YARTEMLEA® (narsoplimab-wuug), Patent No. 9,011,860 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-3828

Patent Term Extension Application for YARTEMLEA® (narsoplimab-wuug), Patent No. 9,011,860

Documents

Comments

Description

OPEN

Comment Period OpensApr 9, 2026

Type	Title	Posted	Comments	Status
Other	Patent Term Extension Application from Covington & Burling LLP (on behalf of Omeros Corporation)	Apr 9, 2026	--

CDER

Patent Term Extension Application

Covington & Burling LLP

Omeros Corporation

YARTEMLEA® (narsoplimab-wuug)

Patent No. 9,011,860

OPEN